Marsh & McLennan (MRSH) stock
Last close $204.66 on 2026-11-19 (-0.37%) · Sector: Financial Services
Marsh & McLennan is a large global professional services company that helps businesses and individuals manage risk, mostly through insurance brokerage and consulting. It makes money mainly from commissions and fees for arranging insurance coverage and from fees for advice on risk, strategy, and people issues.
The company is growing modestly, with revenue up 7.6% over the past year and an operating margin of 21.4%, meaning about 21 cents of each dollar in sales is left after core operating costs. Over the past year the stock returned 11.7% versus 3.7% for the S&P 500, so it beat the broader market, and it trades 4.4% below its 52-week high. Insiders have sold about $5.5 million of stock over the last 90 days and made no purchases, and the stock has usually risen the day after earnings reports, though not always.
Key numbers
- Market cap: $98.0B
- Revenue (last 12 months): $28.45B
- Revenue growth: +7.6%
- Operating margin: 21.4%
- P/E: 24.5
- P/S: 3.4
- Debt to equity: 1.27
- Current ratio: 1.09
Quality score
Overall 31/100 · growth 36 · profitability 46 · financial health 18 · value 24
Performance and risk
1-year return +11.7% vs S&P 500 +3.7% · volatility 27.4% (S&P 500 14.5%) · largest drop -17.1% · beta -0.33
Stock move the day after earnings
- 2026-01-29: +5.5%
- 2026-04-16: +4.4%
- 2026-07-21: -0.3%
- 2026-10-15: +4.6%
Congress trades (90 days)
0 buys, 9 sells
Insider trades (12 months)
Bought $0.0M · sold $21.0M
MRSH stock research · MRSH options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.